Alternative treatment scheme of seminoma for carboplatin, etoposide and bleomycin (CEB)

نویسندگان

چکیده

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Paclitaxel-etoposide-carboplatin/cisplatin versus etoposide-carboplatin/cisplatin as first-line treatment for combined small-cell lung cancer: a retrospective analysis of 62 cases

OBJECTIVE To compare the efficacy and adverse effects of paclitaxel-etoposide-carboplatin/cisplatin (TEP/TCE) regimen with those of etoposide-carboplatin/cisplatin (EP/CE) regimen as first-line treatment for combined small-cell lung cancer (CSCLC). METHODS A retrospective study was conducted on 62 CSCLC patients who were treated at Tianjin Medical University Cancer Institute and Hospital from...

متن کامل

Postenucleation adjuvant chemotherapy with vincristine, etoposide, and carboplatin for the treatment of high-risk retinoblastoma.

BACKGROUND Analysis of 52 eyes with high-risk retinoblastoma managed with postenucleation adjuvant chemotherapy using vincristine sulfate, etoposide phosphate, and carboplatin showed no evidence of systemic metastasis in any case during a mean (range) follow-up of 66 (12-202) months. PURPOSE To determine the efficacy of postenucleation adjuvant chemotherapy with vincristine, etoposide, and ca...

متن کامل

Treatment for Glioblastoma with Carboplatin, Oral Etoposide and Interferon β (CEI): A Phase II Trial

Gioblastoma is one of the most refractory tumors in central nervous system, and the prognosis remains poor. Temozolomide is a first-line agent for newly-diagnosed glioblastoma, but chemotherapy for recurrent or temozolomide-resistant glioblastoma has not been established. To determine whether chemotherapy with carboplatin, oral etoposide, and interferon β (CEI) prolongs survivals of patients be...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Urology

سال: 2018

ISSN: 2307-5279

DOI: 10.26641/2307-5279.21.1.2017.150085